Advertisement
Screener

ARALEZ PHARMACEUTICALS INC. Other Nonoperating Income (Expense)

ARALEZ PHARMACEUTICALS INC. Other Nonoperating Income (Expense)

ARALEZ PHARMACEUTICALS INC. reported Other Nonoperating Income (Expense) of -$212.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.

Discontinued › Income Statement › Other Income

us-gaap:OtherNonoperatingIncomeExpense · last filed 2018-05-08

  • ARALEZ PHARMACEUTICALS INC. other nonoperating income (expense) for the quarter ending 2018-03-31 was -$212.00K, a 151.58% decline year-over-year.
  • ARALEZ PHARMACEUTICALS INC. other nonoperating income (expense) for the quarter ending 2017-12-31 was $78.00K, a 94.13% decline year-over-year.
  • ARALEZ PHARMACEUTICALS INC. other nonoperating income (expense) for the quarter ending 2017-09-30 was $84.00K.
  • ARALEZ PHARMACEUTICALS INC. other nonoperating income (expense) for the quarter ending 2017-06-30 was $109.00K.
  • ARALEZ PHARMACEUTICALS INC. other nonoperating income (expense) for fiscal 2017 was $682.00K, a 88.00% decline from fiscal 2016.
  • ARALEZ PHARMACEUTICALS INC. other nonoperating income (expense) for fiscal 2016 was $5.68M.
  • ARALEZ PHARMACEUTICALS INC. other nonoperating income (expense) for fiscal 2015 was -$143.00K, a 104.61% decline from fiscal 2014.
  • ARALEZ PHARMACEUTICALS INC. other nonoperating income (expense) for fiscal 2014 was $3.10M.
Period endOther Nonoperating Income (Expense) 3 monthOther Nonoperating Income (Expense) 6 monthOther Nonoperating Income (Expense) 9 monthOther Nonoperating Income (Expense) 12 month
2018-03-31-$212.00K
10-Q · filed 2018-05-08
-$134.00K
derived: sum of 2 quarters · filed 2018-05-08
-$50.00K
derived: sum of 3 quarters · filed 2018-05-08
$59.00K
derived: sum of 4 quarters · filed 2018-05-08
2017-12-31$78.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$162.00K
derived: sum of 2 quarters · filed 2018-03-14
$271.00K
derived: sum of 3 quarters · filed 2018-03-14
$682.00K
10-K · filed 2018-03-14
2017-09-30$84.00K
10-Q · filed 2017-11-09
$193.00K
derived: sum of 2 quarters · filed 2017-11-09
$604.00K
10-Q · filed 2017-11-09
$1.93M
derived: sum of 4 quarters · filed 2018-05-08
2017-06-30$109.00K
10-Q · filed 2017-08-09
$520.00K
10-Q · filed 2017-08-09
$1.85M
derived: sum of 3 quarters · filed 2018-05-08
$1.68M
derived: sum of 4 quarters · filed 2018-05-08
2017-03-31$411.00K
10-Q · filed 2018-05-08
$1.74M
derived: sum of 2 quarters · filed 2018-05-08
$1.57M
derived: sum of 3 quarters · filed 2018-05-08
$1.30M
derived: sum of 4 quarters · filed 2018-05-08
2016-12-31$1.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$1.16M
derived: sum of 2 quarters · filed 2018-03-14
$886.00K
derived: sum of 3 quarters · filed 2018-03-14
$5.68M
10-K · filed 2018-03-14
2016-09-30-$173.00K
10-Q · filed 2017-11-09
-$443.00K
derived: sum of 2 quarters · filed 2017-11-09
$4.35M
10-Q · filed 2017-11-09
$4.37M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30-$270.00K
10-Q · filed 2017-08-09
$4.53M
10-Q · filed 2017-08-09
$4.54M
derived: sum of 3 quarters · filed 2018-03-14
$4.55M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31$4.80M
10-Q · filed 2017-05-09
$4.81M
derived: sum of 2 quarters · filed 2018-03-14
$4.83M
derived: sum of 3 quarters · filed 2018-03-14
$4.84M
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31$11.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$28.00K
derived: sum of 2 quarters · filed 2018-03-14
$43.00K
derived: sum of 3 quarters · filed 2018-03-14
-$143.00K
10-K · filed 2018-03-14
2015-09-30$17.00K
10-Q · filed 2016-11-08
$32.00K
derived: sum of 2 quarters · filed 2016-11-08
-$154.00K
10-Q · filed 2016-11-08
2015-06-30$15.00K
10-Q · filed 2016-08-09
-$171.00K
10-Q · filed 2016-08-09
2015-03-31-$186.00K
10-Q · filed 2016-05-10
2014-12-31$3.10M
10-K · filed 2017-03-13